353 related articles for article (PubMed ID: 34006094)
1. Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.
Jain S; Xun G; Abesteh S; Ho S; Lingamaneni M; Martin TA; Tasan I; Yang C; Zhao H
ACS Synth Biol; 2021 Jun; 10(6):1320-1327. PubMed ID: 34006094
[TBL] [Abstract][Full Text] [Related]
2. Solution structure and dynamics of anti-CRISPR AcrIIA4, the Cas9 inhibitor.
Kim I; Jeong M; Ka D; Han M; Kim NK; Bae E; Suh JY
Sci Rep; 2018 Mar; 8(1):3883. PubMed ID: 29497118
[TBL] [Abstract][Full Text] [Related]
3. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
Schindele P; Wolter F; Puchta H
Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
[TBL] [Abstract][Full Text] [Related]
4. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
5. Disabling Cas9 by an anti-CRISPR DNA mimic.
Shin J; Jiang F; Liu JJ; Bray NL; Rauch BJ; Baik SH; Nogales E; Bondy-Denomy J; Corn JE; Doudna JA
Sci Adv; 2017 Jul; 3(7):e1701620. PubMed ID: 28706995
[TBL] [Abstract][Full Text] [Related]
6. Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities.
Clarke R; Terry AR; Pennington H; Hasty C; MacDougall MS; Regan M; Merrill BJ
Mol Cell; 2021 Jan; 81(2):226-238.e5. PubMed ID: 33378644
[TBL] [Abstract][Full Text] [Related]
7. DNA stretching induces Cas9 off-target activity.
Newton MD; Taylor BJ; Driessen RPC; Roos L; Cvetesic N; Allyjaun S; Lenhard B; Cuomo ME; Rueda DS
Nat Struct Mol Biol; 2019 Mar; 26(3):185-192. PubMed ID: 30804513
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
9. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
10. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
Sandoval IM; Collier TJ; Manfredsson FP
Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
12. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
Shou J; Li J; Liu Y; Wu Q
Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
[TBL] [Abstract][Full Text] [Related]
13. Optical Control of Genome Editing by Photoactivatable Cas9.
Otabe T; Nihongaki Y; Sato M
Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
[TBL] [Abstract][Full Text] [Related]
14. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
[TBL] [Abstract][Full Text] [Related]
15. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
16. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
17. Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Marsh S; Hanson B; Wood MJA; Varela MA; Roberts TC
Mol Ther; 2020 Dec; 28(12):2527-2539. PubMed ID: 33171139
[TBL] [Abstract][Full Text] [Related]
18. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
Hiranniramol K; Chen Y; Wang X
Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]